Effects of chronic sertraline hydrochloride administration on vascular endothelial and autonomic function in patients with chronic heart failure.

Trial Profile

Effects of chronic sertraline hydrochloride administration on vascular endothelial and autonomic function in patients with chronic heart failure.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 Jul 2009

At a glance

  • Drugs Sertraline (Primary)
  • Indications Depressive disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Jul 2009 Actual patient number (4) added as reported by ClinicalTrials.gov.
    • 24 Jul 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 24 Jul 2009 Planned end date changed from 1 Jun 2008 to 1 Jul 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top